BAMCO Inc
RDY icon

BAMCO Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

BAMCO Inc’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,921,495
Closed -$25M – 420
2021
Q3 		$25M Sell
1,921,495
-7,835
-0.4% -$104K 0.06% 239
2021
Q2 		$28.4M Buy
1,929,330
+7,490
+0.4% +$105K 0.06% 227
2021
Q1 		$23.6M Buy
1,921,840
+206,120
+12% +$2.65M 0.06% 216
2020
Q4 		$24.5M Sell
1,715,720
-537,240
-24% -$7.23M 0.06% 198
2020
Q3 		$31.3M Buy
2,252,960
+199,265
+10% +$2.37M 0.1% 154
2020
Q2 		$21.8M Buy
2,053,695
+15,900
+0.8% +$162K 0.08% 164
2020
Q1 		$16.4M Buy
2,037,795
+148,810
+8% +$1.24M 0.08% 154
2019
Q4 		$15.3M Sell
1,888,985
-31,005
-2% -$245K 0.06% 185
2019
Q3 		$14.6M Buy
1,919,990
+268,190
+16% +$1.99M 0.06% 180
2019
Q2 		$12.4M Buy
1,651,800
+1,419,875
+612% +$11.2M 0.05% 202
2019
Q1 		$1.88M Buy
+231,925
New +$1.76M 0.01% 287

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BAMCO Inc's RDY Position: Q4 2021 in Review

BAMCO Inc sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 1,921,495 shares — an estimated $25M sold.

BAMCO Inc first reported a position in RDY in Q1 2019 and held it in 11 quarters. The position peaked at $31.3M in Q3 2020. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • BAMCO Inc reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • BAMCO Inc sold 1,921,495 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $25M.
  • BAMCO Inc first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 11 quarters.
  • BAMCO Inc's Dr. Reddy's Laboratories position peaked at $31.3M in Q3 2020.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on BAMCO Inc's 13F filing for Q4 2021, filed 14 Feb 2022.